Modelling human development and disease in pluripotent stem-cell-derived gastric organoids
Source McCracken et al., 2014 · Cincinnati Children's Hospital Medical Center, Division of Developmental Biology · 10.1038/nature13863
Abstract
This protocol describes the directed differentiation of human pluripotent stem cells (ESCs and iPSCs) into three-dimensional human gastric organoids (hGOs) recapitulating antral development. hGOs contain surface mucous cells, antral gland cells, endocrine cells, and LGR5+ stem cells, and model physiological responses to Helicobacter pylori infection including CagA-dependent epithelial proliferation.
Protocol overview
16 steps across 5 phases
- 1 Culture pluripotent stem cells in feeder-free conditions
- 1 Plate pluripotent stem cells as single cells
- 2 Induce definitive endoderm
- 1 Establish foregut patterning conditions
- 2 Add retinoic acid on day 5
- 3 Harvest foregut spheroids
- 1 Continue retinoic acid treatment for antral specification
- 2 Transfer spheroids to three-dimensional Matrigel culture
- 3 Overlay with gut media containing EGF
- 4 Maintain organoid culture for maturation
- 5 Optional: Re-plate organoids at day 20
- 6 Optional: Reduce EGF for endocrine differentiation
- 1 Prepare H. pylori inoculum
- 2 Microinject H. pylori into organoid lumen
- 3 Culture infected organoids for 24 hours
- 4 Harvest infected organoids for analysis
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in McCracken et al., 2014. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol